Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management of multiple sclerosis.

S M Leary1, A J Thompson

  • 1Institute of Neurology, University College, London, UK.

International Journal of Clinical Practice
|June 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B.

The Journal of infectious diseases·2025
Same author

Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial.

Journal of viral hepatitis·2025
Same author

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B.

Alimentary pharmacology & therapeutics·2025
Same author

New insights into the effects of ethylene on ABA catabolism, sweetening and dormancy in stored potato tubers.

Postharvest biology and technology·2021
Same author

Direct Measurement of Single-Molecule Ligand-Receptor Interactions.

The journal of physical chemistry. B·2020
Same author

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2019
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Multiple sclerosis management requires a shift towards evidence-based practices. While new therapies offer partial disease modification, comprehensive rehabilitation and symptomatic treatment remain crucial for addressing neurological deficits in multiple sclerosis care.

Area of Science:

  • Neurology
  • Clinical Medicine
  • Disease Management

Background:

  • Multiple sclerosis (MS) is a complex neurological condition.
  • Recent advancements include partially effective disease-modifying therapies.
  • Current treatments do not reverse existing neurological deficits.

Purpose of the Study:

  • To review the current state of multiple sclerosis management.
  • To emphasize the importance of non-pharmacological interventions.
  • To advocate for evidence-based and consensus-driven clinical practice.

Main Methods:

  • Literature review of recent therapeutic advancements in MS.
  • Analysis of the role of supportive and rehabilitative measures.
  • Discussion on the transition from empirical to evidence-based clinical guidelines.

Related Experiment Videos

Main Results:

  • New therapies offer partial disease modification but do not restore neurological function.
  • Supportive measures, symptomatic treatment, and rehabilitation are essential components of MS care.
  • A move towards evidence-based practice and consensus opinion is needed for improved patient outcomes.

Conclusions:

  • Effective multiple sclerosis management integrates disease-modifying therapies with comprehensive supportive care.
  • Evidence-based practice and expert consensus are vital for optimizing clinical decision-making in MS.
  • Future improvements in multiple sclerosis care depend on a holistic, data-driven approach.